Value of Tax Appeals Commission cases fell 63% in 2021 The quantum in disputed tax cases before the Tax Appeals Commission (TAC) last year plummeted by €2.85 billion or 63% from €4.5 billion to €1.65 … Business • 21 Apr 22
Perrigo settles €1.64bn tax bill with Revenue for €297m Drugmaker company, Perrigo, has settled its long-running dispute with Revenue over a €1.64bn tax bill, for just under €300m. Business • 30 Sep 21
Perrigo says Revenue has rejected tax offer US drugmaker Perrigo has said that Revenue has rejected an offer to settle a €1.64 billion tax bill it claims the company owes for back … Business • 13 May 21
High Court to rule next week on Perrigo tax case A High Court judge will give judgment next week on an action by pharmaceutical company Perrigo against the Revenue and State. Business • 30 Oct 20
Pharmaceutical firm contests €1.6 billion tax bill The Commercial Court has begun hearing arguments in a judicial review of a decision by Revenue to issue a tax bill of €1.64 billion to … Courts • 04 Jun 20
Perrigo action over disputed €1.64bn tax bill adjourned A judicial review of a decision by Revenue to issue pharmaceutical company Perrigo with a tax bill for €1.64bn will not now formally begin until … Business • 03 Jun 20
Perrigo seeks judicial review of €1.6bn tax ruling An Irish registered pharmaceutical company has been granted permission by the High Court to bring a judicial review application aimed at overturning a €1.6 billion … Business • 25 Feb 19
Revenue issues €1.6 billion tax demand against Perrigo The Revenue Commissioners have issued pharmaceutical company Perrigo, formerly known as Elan, with a tax demand for €1.6 billion. Business • 21 Dec 18
US firm Perrigo to move some functions to Ireland US pharmaceutical firm Perrigo has announced that a number of its key public facing corporate functions will be relocated to Ireland as part of the … Business • 19 Feb 16
Perrigo profit misses for first time in 5 quarters Drugmaker Perrigo's profit missed market estimates for the first time in five quarters due to higher costs and disappointing performance in its branded consumer healthcare … Business • 18 Feb 16
AstraZeneca sells US drug rights to Perrigo AstraZeneca has finalised plans to divest its Crohn's disease drug Entocort by selling US rights to the medicine to Perrigo for $380m. Business • 23 Nov 15
Perrigo announces plans for Irish operations Perrigo, the drugs company that bought out Elan, has announced plans to consolidate more of its operations here. Business • 23 Oct 15
45 merger and acquisition deals in early 2015 There were 45 merger and acquisitions deals in Ireland during the first half of the year, according to corporate lawyers William Fry. Business • 04 Aug 15
Dublin-based Perrigo rejects Mylan's latest bid Generic drug company Mylan has raised its bid for a second time for Perrigo, offering $35.6 billion for the over-the-counter giant, but the offer has … Business • 29 Apr 15
Mylan rejects Teva offer, but leaves door open Mylan has today rejected Teva Pharmaceutical Industries' unsolicited $40 billion takeover offer, but left the door open for talks. Business • 27 Apr 15
Teva makes $40 billion offer for rival Mylan Generic drugmaker Teva Pharmaceutical Industries has proposed buying smaller rival Mylan for $40 billion. Business • 21 Apr 15
Mylan offers to acquire Perrigo for $28.9bn Pharmaceutical giant Mylan offered to acquire Dublin-based healthcare supplier Perrigo for $28.9bn in the latest proposed mega-merger in the pharmaceutical sector. Business • 08 Apr 15
Perrigo completes Elan deal Perrigo has completed the acquisition of Elan in a deal valued at about $8.6 billion. Business • 19 Dec 13
Elan and Perrigo get High Court approval for deal Elan has said the High Court has approved the sale of the company to pharmaceutical firm Perrigo. Business • 13 Dec 13
Elan shareholders approve Perrigo takeover deal Elan’s shareholders have given approval to the company’s acquisition by pharmaceutical firm Perrigo. Business • 18 Nov 13
Perrigo keen to complete Elan deal by year end US pharmaceutical company Perrigo has said it is working hard to close its acquisition of Elan by the end of the year. Business • 01 Nov 13
US drugmaker Perrigo to buy Elan for $8.6 billion US generic drugmaker Perrigo has agreed to buy Dublin based drug company Elan for $8.6 billion. Business • 29 Jul 13
